Nomura Securities Upgrades Novo Nordisk (NVO) to Buy Post CRL Sell-Off
Tweet Send to a Friend
Nomura Securities upgraded Novo Nordisk (NYSE: NVO) from Neutral to Buy, which follows Monday's 14 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
